MétaCan
Menu
Back to cohort
Record W3126979568 · doi:10.1176/appi.focus.19107

Combinatorial Pharmacogenomic Testing Improves Outcomes for Older Adults With Depression

2021· article· en· W3126979568 on OpenAlexfundno aff
Brent P. Forester, Sagar V. Parikh, Sara L. Weisenbach, Olusola Ajilore, Ipsit V. Vahia, Anthony J. Rothschild, Michael E. Thase, Boadie W. Dunlop, Charles DeBattista, Charles R. Conway, Richard C. Shelton, Matthew Macaluso, James Li, Paul Traxler, Jennifer Logan, Lisa Brown, Bryan Dechairo, John F. Greden

Bibliographic record

VenueFOCUS The Journal of Lifelong Learning in Psychiatry · 2021
Typearticle
Languageen
FieldMedicine
TopicFrailty in Older Adults
Canadian institutionsnot available
FundersJanssen PharmaceuticalsH. Lundbeck A/SSpier Family FoundationRogers Family FoundationAssurex HealthCerecorAllerganNational Institutes of HealthSage TherapeuticsCanadian Network for Mood and Anxiety TreatmentsCanadian Institutes of Health ResearchSunovionAgency for Healthcare Research and QualitySanofiBiogenGlaxoSmithKlineNovartisNational Institute of Mental HealthPfizerEli Lilly and CompanyAstraZenecaACADIA Pharmaceuticals
KeywordsDepression (economics)PharmacogenomicsMedicineGerontologyPsychologyPsychiatryPharmacologyEconomics

Abstract

fetched live from OpenAlex

Objective: Evaluate the clinical utility of combinatorial pharmacogenomic testing for informing medication selection among older adults who have experienced antidepressant medication failure for major depressive disorder (MDD). Design: Post hoc analysis of data from a blinded, randomized controlled trial comparing two active treatment arms. Setting: Psychiatry specialty and primary care clinics across 60 U.S. community and academic sites. Participants: Adults age 65 years or older at baseline (n = 206), diagnosed with MDD and inadequate response to at least one medication on the combinatorial pharmacogenomic test report during the current depressive episode. Intervention: Combinatorial pharmacogenomic testing to inform medication selection (guided-care), compared with treatment as usual (TAU). Outcomes: Mean percent symptom improvement, response rate, and remission rate at week 8, measured using the 17-item Hamilton Depression Rating Scale; medication switching; and comorbidity moderator analysis. Results: At week 8, symptom improvement was not significantly different for guided-care than for TAU (A = 8.1%, t=1.64, df= 187; p = 0.102); however, guided-care showed significantly improved response (A = 13.6%, t = 2.16, df= 187; p = 0.032) and remission (A = 12.7%, t = 2.49, df= 189; p = 0.014) relative to TAU. By week 8, more than twice as many patients in guided-care than in TAU were on medications predicted to have no gene-drug interactions (x = 19.3, df=2;p <0.001). Outcomes in the guided-care arm showed consistent improvement through the end of the open-design 24-week trial, indicating durability of the effect. Differences in outcomes between arms were not significantly impacted by comorbidities. Conclusions: Combinatorial pharmacogenomic test-informed medication selection improved outcomes over TAU among older adults with depression. (Reprinted with permission from Am J Geriatr Psychiatry 2020; 28:933–945)

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.032
Threshold uncertainty score0.556

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.011
GPT teacher head0.282
Teacher spread0.271 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2021
Admission routes1
Has abstractyes

Explore more

Same venueFOCUS The Journal of Lifelong Learning in PsychiatrySame topicFrailty in Older AdultsFrench-language works237,207